A review on polymeric micellar nanocarriers

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 2, 2011, Pages 109-116

  Dhembre, G N ^a   Moon, R S ^a   Kshirsagar, R V ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Pluronic block copolymers; Polymeric nanoparticles

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; COPOLYMER; DOXORUBICIN; MACROGOL; NANOCARRIER; PACLITAXEL; POLOXAMER; POLYMER;

AQUEOUS SOLUTION; BLOOD BRAIN BARRIER; BREAST CANCER; CRITICAL MICELLE CONCENTRATION; DEGENERATIVE DISEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; ESOPHAGEAL ADENOCARCINOMA; GENE TARGETING; HALF LIFE TIME; HEMOLYSIS; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MICELLE; MICELLIZATION; MYCOSIS; NANOTECHNOLOGY; NONHUMAN; OCULAR DRUG DELIVERY SYSTEM; PANCREAS CANCER; REVIEW; SOLID TUMOR; STOMACH CANCER;

EID: 84855516638     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Chris Oerlemans & Wouter Bult & Mariska Bos & Gert Storm & J. Frank W. Nijsen & Wim E. Hennink: 27 July 2010 Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release27 July 2010
2. Matsumura Y, Kataoka K. Preclinical and clinical studies of anticancer agentincorporating polymer micelles. Cancer Sci. 2009;100:572-9.
3. Ramesh C. Nagarwal a, Shri Kant b, P.N. Singh a, P. Maiti c, J.K. Pandit Review Polymeric nanoparticulate system: A potential approach for ocular drug delivery Journal of Controlled Release 136 (2009) 2-13
4. M. Hamidi, A. Azadi, P. Rafiei, Hydrogel nanoparticles in drug delivery, Adv. Drug Deliv. Rev. 60 (2008) 1638-1649
5. Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat. 2008;108:241-50.
6. Podoltsev NA, Rubin M, Figueroa J, Lee MY, Kwonj J, Yu J, et al. Phase II clinical trial of paclitaxel loaded polymeric micelle (GPM) in patients (pts) with advanced pancreatic cancer (APC): J Clin Oncology. 26: 2008 (May 20 suppl; abstr 4627).
7. Matsumura Y. Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol. 2008;38:793-802.
8. Wilson RH, Plummer R, Adam J, Eatock M, Boddy AV, Griffin M, et al. Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles. J Clin Oncol. 26: 2008 (May 20 suppl; abstr 2573).
9. V.P. Torchilin, Targeted pharmaceutical nanocarriers for cancer therapy and imaging, AAPS J. 9 (2007) 128-147
10. Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, et al. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer. 2007;97:170-6.
11. P. Couvreur, C. Vauthier, Nanotechnology: intelligent design to treat complex disease, Pharm. Res. 23 (7) (2006) 1417-1450.
12. Groneberg DA, Giersig M, Welte T. Nanoparticle-based diagnosis and therapy. Curr Drug targets. 2006; 7: 643-648.
13. Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 2006; 58: 1456-1459.
14. Croy SR and Kwon GS (2004) The effects of Pluronic block copolymers on the aggregation state of nystatin./Control Rel 95:161-171.
15. La Van DA, Lynn DM and Langer R (2002) Moving smaller in drug discovery anddelivery. Nat Rev Drug Discov 1:77.
16. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev.2001; 46: 3-26
17. Fernandez AM, Van Derpoorten K, Dasnois L, et al. N-Succinyl- (beta-alanyl-L-leucyl-Lalanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity. J MedChem. 2001; 44: 3750-3753.
18. West JL and Halas NJ (2000) Applications of nanotechnology to biotechnology commentary. Curr Opin Biotechnol 11:215.
19. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, et al. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res. 2004;10:3708-16.
20. Kwon GS (2003) Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carr Syst 20:357-403.
21. Adams ML, Andes DR and Kwon GS (2003) Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(Lamino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules 4:750-757.
22. Jagannath C, Sepulveda E, Actor JK, Luxem F, Emanuele MR and Hunter RL (2000) Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide- mediated killing of Mycobacterium avium by macrophages. Immunopharmacology 48:185-197. 92 Batrakova et al.
23. Jagannath C, Emanuele MR and Hunter RL (2000) Activity of poloxamer CRL- 1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice. Int J Antimicrob Agents 15:55-63.
24. M. Jones and J. Leroux. Polymeric micellesVa new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:101Y111(1999).
25. Jagannath C, Emanuele MR and Hunter RL (1999) Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice. Antimicrob Agents Chemother 43:2898-2903.
26. Jagannath C, Wells A, Mshvildadze M, Olsen M, Sepulveda E, Emanuele M, Hunter RL, Jr. and Dasgupta A (1999) Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. Life Sci 64:1733-1738.
27. Batrakova EV, Han HY, Miller DW and Kabanov AV (1998) Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
28. A. Martin (ed.), Physical Pharmacy. Lippinkott, Williams and Wilkins, Philadelphia, 1993.
29. Kabanov AV, Batrakova EV, Melik-Nubarov NS, Fedoseev NA, Dorodnich TY, Alakhov VY, Chekhonin VP, Nazarova IR and Kabanov VA (1992) A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers
30. Kabanov AV, Chekhonin VP, Alakhov VY, Batrakova EV, Lebedev AS, Melik-Nubarov NS, Arzhakov SA, Levashov AV, Morozov GV, Severin ES and Kabanov VA (1989) The neuroleptic activity of haloperidol increases after its solubilization in surfactant
31. Yalkowsky SH, ed. Techniques of Solubilization of Drugs. New York, NY: M Dekker; 1981